v3.25.2
FAIR VALUE MEASUREMENTS (Tables)
6 Months Ended
Jun. 30, 2025
Fair Value Disclosures [Abstract]  
Schedule of Fair Value Level of Inputs Below are the three levels of inputs that may be used to measure fair value:
Level 1Quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.
Level 2Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
Key assumptions used to apply this pricing model were as follows:
20252024
Expected term (years)2.812.81
Risk-free interest rate3.91 %4.31 %
Annualized volatility27.91 %26.75 %
Schedule of Fair Value of Assets and Liabilities Measured on a Recurring Basis The fair values of the Company’s financial assets and liabilities that are required to be measured on a recurring basis at fair value were as follows:
 June 30, 2025December 31, 2024
 Fair Value Measurements UsingFair Value Measurements Using
 Level 1Level 2Level 3Level 1Level 2Level 3
Assets:
Investments in equity securities (1)$218.2 $4.0 — $98.6 $5.3 — 
_______________
(1)Investments in equity securities are recorded in Notes receivable and other non-current assets in the consolidated balance sheets at fair value. Unrealized holding gains and losses for equity securities are recorded in Other income (expense) in the consolidated statements of operations in the current period. During the three and six months ended June 30, 2025 and 2024, the Company recognized unrealized gains of $110.7 million, $40.7 million, $118.3 million and $26.0 million, respectively, for equity securities held as of June 30, 2025.
Schedule of Contractual Amounts of Outstanding Instruments
The following table presents the contractual amounts of the Company's outstanding instruments:
As of
 DesignationJune 30, 2025December 31, 2024
 Foreign currency-denominated debt (1)Net Investment Hedge$5,480.9 $— 
_______________
(1)During the three and six months ended June 30, 2025, the Company recorded $204.6 million of unrealized foreign currency losses related to the EUR denominated debt that was designated as a net investment hedge as a foreign currency translation adjustment in Accumulated other comprehensive loss. As of June 30, 2025, includes 4.7 billion EUR ($5.5 billion) of outstanding EUR denominated debt designated as hedges of a portion the Company’s net investment in foreign operations. This debt matures in fiscal years 2026 through 2034.